Epigenetic Drivers of Cancer Metastasis: From Methylation to Non-Coding RNAs

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 30 December 2025 | Viewed by 41

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biochemistry, School of Pharmacy, Aichi Gakuin University, Aichi, Japan
Interests: epigenetics; cancer metastasis; methylation; noncoding RNAs

Special Issue Information

Dear Colleagues,

This Special Issue aims to highlight how epigenetic mechanisms—including DNA and RNA methylation, as well as non-coding RNAs—drive cancer metastasis. Metastasis, the leading cause of cancer-related mortality, involves complex regulatory processes that are still not fully understood. Recent findings suggest that aberrant methylation of DNA and RNA has a significant impact on gene function and expression, thereby enhancing tumor invasiveness and metastatic potential. Additionally, non-coding RNAs, such as microRNAs and long non-coding RNAs, have emerged as modulators of metastasis through interactions with epigenetic modifiers.

We encourage researchers interested in recent epigenetic advances to contribute studies elucidating novel roles of epigenetic modifiers in cancer metastasis. Review articles covering related research are also welcome for consideration in this Special Issue.

Dr. Toshifumi Hara
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epigenetics
  • metastasis
  • DNA methylation
  • RNA methylation
  • non-coding RNAs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop